Safety and Tolerability of MRZ-99030 Eye Drops in Healthy Volunteers and Glaucoma Patients
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
- To assess the safety and tolerability of repeat dose topical administration of MRZ-99030
Ophthalmic Solution with ascending doses in healthy subjects (stage 1) and glaucoma
subjects (stage 2).
- To assess plasma pharmacokinetics and urine concentration of MRZ- 99030 and its
metabolite MRZ-9499 after single and repeat dose topical administration of MRZ-99030
Ophthalmic Solution.